Launspach M, Temel D, Ohlendorf E, Zirngibl F, Materne B, Oevermann L, Deubzer HE, Henssen AG, Künkele A, Hundsdörfer P, Bernuth H von, Pruß A, Eggert A, Stackelberg A von, Lang P, Schulte JH. Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study. haematol [Internet]. 2022Sep.22 [cited 2023Dec.1];108(1):267-72. Available from: https://haematologica.org/article/view/haematol.2022.281134